Gene · 9261
Papers3,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intestinal Flora-Derived Kynurenic Acid Protects Against Intestinal Damage Caused by Candida albicans Infection via Activation of Aryl Hydrocarbon Receptor. | Front Microbiol | 2022 | 35923391 | PubTator, text mining | PubMed |
| The Conserved CNOT1 Interaction Motif of Tristetraprolin Regulates ARE-mRNA Decay Independently of the p38 MAPK-MK2 Kinase Pathway. | Mol Cell Biol | 2022 | 35920669 | PubTator, text mining | PubMed |
| Prediction of the Active Components and Mechanism of Forsythia suspensa Leaf against Respiratory Syncytial Virus Based on Network Pharmacology. | Evid Based Complement Alternat Med | 2022 | 35911158 | PubTator, text mining | PubMed |
| MAPPINGS, a tool for network analysis of large phospho-signalling datasets: application to host erythrocyte response to Plasmodium infection. | Curr Res Microb Sci | 2022 | 35909628 | PubTator, text mining | PubMed |
| A glance into the future of diagnosis and treatment of spondyloarthritis. | Ther Adv Musculoskelet Dis | 2022 | 35898564 | PubTator, text mining | PubMed |
| Increased cytochrome C threonine 50 phosphorylation in aging heart as a novel defensive signaling against hypoxia/reoxygenation induced apoptosis. | Aging (Albany NY) | 2022 | 35896004 | PubTator, text mining | PubMed |
| T-Cell Intracellular Antigen 1-Like Protein in Physiology and Pathology. | Int J Mol Sci | 2022 | 35887183 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets. | Cell Death Discov | 2022 | 35879279 | PubTator, text mining | PubMed |
| Inflammatory gene expression during acute high-altitude exposure. | J Physiol | 2022 | 35875936 | PubTator, text mining | PubMed |
| Circulatory Level of Inflammatory Cytoskeleton Signaling Regime Proteins in Cancer Invasion and Metastasis. | Front Oncol | 2022 | 35875090 | PubTator, text mining | PubMed |
| Elevated intracellular Na+ and osmolarity stimulate catalytic activity of the ubiquitin ligase Nedd4-2. | Proc Natl Acad Sci U S A | 2022 | 35858421 | PubTator, text mining | PubMed |
| ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasome. | Science | 2022 | 35857590 | PubTator, text mining | PubMed |
| DOCKSTRING: Easy Molecular Docking Yields Better Benchmarks for Ligand Design. | J Chem Inf Model | 2022 | 35849793 | PubTator, text mining | PubMed |
| Fluorine-18: Radiochemistry and Target-Specific PET Molecular Probes Design. | Front Chem | 2022 | 35844642 | PubTator, text mining | PubMed |
| Phosphorylation of mixed lineage kinase MLK3 by cyclin-dependent kinases CDK1 and CDK2 controls ovarian cancer cell division. | J Biol Chem | 2022 | 35843311 | PubTator, text mining | PubMed |
| Recent clinical findings on the role of kinase inhibitors in COVID-19 management. | Life Sci | 2022 | 35841979 | PubTator, text mining | PubMed |
| Investigation of the Mechanism of Periploca forrestii against Rheumatoid Arthritis with Network Pharmacology-Based Analysis. | Evid Based Complement Alternat Med | 2022 | 35836835 | PubTator, text mining | PubMed |
| Inflammasome activation: from molecular mechanisms to autoinflammation. | Clin Transl Immunology | 2022 | 35832835 | PubTator, text mining | PubMed |
| The treatment of advanced non-small cell lung cancer harboring KRAS mutation: a new class of drugs for an old target-a narrative review. | Transl Lung Cancer Res | 2022 | 35832439 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9261/papers?page=26